Short And Intermediate Term Clinical Outcome Of Coronary Revascularization In Patients With Multi-vessel Diseases

Revascularisation of patient with multivessel coronary artery disease is complex and important field in therapy of coronary heart diease , Approximately two thirds of patients who require revascularisation have multi-vessel disease. Coronary artery bypass grafting (CABG) remains the standard of care for patients with multivessel disease because it can easily require more complete vascularisation. And However,percutaneous coronary intervention (PCI) has progressed through simple balloon angioplasty, to bare metal coronary stents(BMS), and then drug-eluting stents(DES), and is now challenging coronary artery bypass graft surgery as the gold standard for treatment of these patients with multivessel coronary artery disease. In 2001, published results of RAVEL trial indicated that drug-eluting stents implantation markedly reduced the incidence of restenosis and repeat revascularization in selected patient, which bring us into a new epoch of percutaneous treatment of coronary artery disease. Subsequent serial SIRIUS study demonstrate that drug-eluting stents implantation was efficacy and safety in long vessel lesion and small vessel lesion. But the data mainly support use in more simple anatomy. Published data on the use of drug-eluting stents in the treatment of three-vessel...